Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comprehensive strategy for the design of precision drugs and identification of genetic signature behind proneness of the disease-a pharmacogenomic approach.

Functional & integrative genomics - 1 Jul 2017

Iyer Preethi M, Karthikeyan S, Sanjay Kumar P, Krishnan Namboori P K

Abstract excerpt

The proneness of diseases and susceptibility towards drugs vary from person to person. At present, there is a strong demand for the personalization of drugs. The genetic signature behind proneness of the disease has been studied through a comprehensive 'octopodial approach'. All the genetic variants included in the approach have been introduced. The breast cancer associated with BRCA1 mutation has been taken as...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to BRCA1 Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Breast Neoplasms

Share to Drug Design

Share to Genetic Predisposition to Disease

Share to Pharmacogenetics

Share to Polymorphism, Single Nucleotide

Share to Precision Medicine

Source

Identifiers

PMID: 28470340
DOI: 10.1007/s10142-017-0559-7

Genes

BRCA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comprehensive strategy for the design of precision drugs and identification of genetic signature behind proneness of the disease-a pharmacogenomic approach.PMID 28470340Read ↗

Pharmacogenomics in Tailoring First-Line Therapy for Breast Cancer: PharmGKB Database InsightsSemantic proximity Read ↗

Personalised cancer medicine.Semantic proximity Read ↗

Review: Precision medicine and driver mutations: Computational methods, functional assays and conformational principles for interpreting cancer drivers.Semantic proximity Read ↗

[Personalized medicine].Semantic proximity Read ↗

Development of precision medicine approaches based on inter-individual variability of BCRP/ABCG2Semantic proximity Read ↗

Shared genetics between breast cancer and predisposing diseases identifies novel breast cancer treatment candidatesSemantic proximity Read ↗

A piece in the puzzle of personalized medicine.Semantic proximity Read ↗

Pharmacogenetics and pharmacogenomics: a bridge to individualized cancer therapy.Semantic proximity Read ↗

Foundations, promises and uncertainties of personalized medicine.Semantic proximity Read ↗

Pharmacogenetics of anti-cancer drugs: State of the art and implementation – recommendations of the French National Network of PharmacogeneticsSemantic proximity Read ↗

The effect of genetic variability on drug response in conventional breast cancer treatment.Semantic proximity Read ↗

Shared genetics between breast cancer and predisposing diseases identifies novel breast cancer treatment candidates.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.